Cubist Systematic Strategies’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$414K Buy
+16,161
New +$355K ﹤0.01% 2368
2022
Q4
Sell
-1,655
Closed -$33K 4229
2022
Q3
$33K Sell
1,655
-758
-31% -$18.3K ﹤0.01% 4180
2022
Q2
$61K Buy
+2,413
New +$55.5K ﹤0.01% 4062
2022
Q1
Sell
-2,971
Closed -$83K 3547
2021
Q4
$83K Buy
2,971
+1,400
+89% +$45.9K ﹤0.01% 3235
2021
Q3
$66K Sell
1,571
-1,202
-43% -$50.4K ﹤0.01% 2805
2021
Q2
$129K Sell
2,773
-2,304
-45% -$114K ﹤0.01% 2683
2021
Q1
$280K Sell
5,077
-5,431
-52% -$360K ﹤0.01% 2295
2020
Q4
$763K Buy
+10,508
New +$1.23M 0.01% 1546
2019
Q4
Sell
-1,987
Closed -$234K 2405
2019
Q3
$234K Sell
1,987
-220
-10% -$33.3K ﹤0.01% 1693
2019
Q2
$357K Sell
2,207
-30
-1% -$5.7K 0.01% 1686
2019
Q1
$528K Buy
2,237
+744
+50% +$188K 0.02% 1162
2018
Q4
$405K Buy
+1,493
New +$432K 0.02% 1090
2018
Q2
Sell
-747
Closed -$440K 1775
2018
Q1
$440K Buy
+747
New +$463K 0.03% 891

Other funds holding ASMB

Cubist Systematic Strategies's ASMB Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Assembly Biosciences (ASMB) in Q3 2025: 16,161 shares worth $414K. The stake represents ﹤0.01% of the portfolio and ranks #2368 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in ASMB as recently as Q3 2022.

Cubist Systematic Strategies first reported a position in ASMB in Q1 2018 and has held it in 13 quarters since. The position peaked at $763K in Q4 2020. 57 funds tracked by Wall St. Rank hold ASMB as of Q3 2025.

  • Cubist Systematic Strategies held 16,161 shares of Assembly Biosciences worth $414K as of Q3 2025.
  • Assembly Biosciences was a new Cubist Systematic Strategies position in Q3 2025.
  • Assembly Biosciences made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2368 holding.
  • Cubist Systematic Strategies first reported a position in Assembly Biosciences in Q1 2018 and has held it in 13 quarters since.
  • Cubist Systematic Strategies's Assembly Biosciences position peaked at $763K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.